IMT Inspiratory Muscle Training in Older Heart Failure Patients

TL;DR: This is a very small (20-participant) completed pilot trial of inspiratory muscle training in adults aged 70+ with end-stage heart failure. Results are posted, but the study was designed mainly to test feasibility — it is early, exploratory evidence, not proof of benefit.

What is IMT inspiratory muscle training, and what did this trial test?

IMT inspiratory muscle training is a form of breathing exercise that strengthens the muscles you use to inhale — mainly the diaphragm — usually by breathing in against resistance through a small handheld inspiratory muscle training (IMT) device. The idea is that stronger breathing muscles may improve exertion, fatigue and daily function.

This University of Pittsburgh trial (NCT06576297) enrolled 20 adults aged 70 or older living with heart failure — a condition in which the heart cannot pump blood as efficiently as the body needs. All participants had advanced disease and had been referred to palliative care, which focuses on comfort and quality of life rather than cure. The trial included both heart failure with reduced ejection fraction and heart failure with preserved ejection fraction (the two main pump-function subtypes).

Participants were randomly assigned to either a 12-week home-based IMT program or standard of care alone. It was an interventional, randomized design with no assigned trial phase.

What did the trial measure?

The primary outcome was completion of the 3-month assessment — in other words, whether these frail, seriously ill older adults could actually stick with and complete a home-based inspiratory muscle training IMT program. That focus tells you this was a feasibility-oriented pilot, not a large efficacy study.

Alongside that, the posted results report several secondary measures comparing the IMT group with standard of care:

• Change in MIP (Maximum Inspiratory Pressure) — a biomarker of how strong the inhaling muscles are.
• Change in Sit-to-Stand Time — a measure of lower-body strength and mobility.
• Change in Gait Speed — how fast a person walks, a well-validated marker of frailty and function.

Results for these outcomes are now posted on ClinicalTrials.gov. Because the registry entry does not provide specific effect sizes here, we are not stating numbers or a verdict — only what was measured. For context on why walking pace and strength matter in aging, see our overview of grip strength and mobility testing.

How much weight should a longevity reader give this?

Not much on its own — and that is by design. With only 20 participants and a primary goal of testing feasibility, this trial can suggest whether IMT is doable and safe in a very frail population, but it cannot establish that inspiratory muscle training improves survival, function or quality of life. Findings in end-stage heart failure patients in palliative care also may not apply to healthier older adults.

Frequently asked questions